论文部分内容阅读
目的:分析阴道炎实施药物联合治疗的临床效果。方法:选取我院收治的阴道炎患者76例,将其随机分为两个组别,其中对照组(仅使用硝呋太尔制霉素阴道软胶囊进行治疗)、试验组(联合使用硝呋太尔制霉素阴道软胶囊+乳酸菌阴道胶囊进行治疗)各38例。观察临床疗效,比较用药毒副作用和复发情况。结果:试验组患者治疗有效37例(97.4%),不良反应发生2例(5.3%),病情复发1例(2.6%);对照组患者治疗有效31例(81.6%),不良反应发生8例(21.1%),病情复发6例(15.8%)。P<0.05,差异有统计学意义。结论:针对阴道炎患者,硝呋太尔制霉素阴道软胶囊、乳酸菌阴道胶囊联合应用能够提高临床疗效,减少不良反应和复发情况,值得临床推广。
Objective: To analyze the clinical effect of drug combination therapy on vaginitis. Methods: Totally 76 patients with vaginitis admitted to our hospital were randomly divided into two groups. The control group (nifuratel nystatin vaginal soft capsule for treatment), the experimental group Tai Seoul nystatin vaginal soft capsule + lactic acid bacteria vaginal capsules for treatment) in 38 cases. Observed the clinical curative effect, compared the poisonous side effect and the relapse situation. Results: 37 cases (97.4%) were treated in trial group, 2 cases (5.3%) were adverse reactions, and 1 case (2.6%) was in relapse. The control group was treated effectively in 31 cases (81.6%) and adverse reactions in 8 cases (21.1%), 6 cases (15.8%) were relapsed. P <0.05, the difference was statistically significant. Conclusion: The combination of nifuratel Nyconitine vaginal soft capsule and lactic acid bacteria vaginal capsule can improve the clinical curative effect and reduce the adverse reaction and relapse, which is worthy of clinical promotion.